Cite
MLA Citation
Vince B. C. Biemans et al.. “Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti‐TNF treatment.” Alimentary pharmacology & therapeutics, vol. 52, no. 1, 2020, pp. 123–134. http://access.bl.uk/ark:/81055/vdc_100102757186.0x000043